- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2013
- Public Summary Document (PSD) July 2013 PBAC Meeting - PDF
Trastuzumab emtansine – July 2013
Trastuzumab emtansine, injection, 100 mg and 160 mg, Kadcyla®
Last updated
8 November 2023